Stories this photo appears in:
Immunotherapy treatments and side effects, targeted therapy advances, new oncology provider training and an international drug discovery resource - MD Anderson Research Highlights Dec. 19, 2022
Insights into immunotherapy treatments and side effects, targeted therapy advances, new oncology provider training and an international drug discovery resource
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a cell cycle checkpoint inhibitor with potential therapeutic effects in an ovarian cancer subtype, a telementoring program for French-speaking oncology providers in Africa, insights into the relationship between obesity and immunotherapy side effects, updates to the world’s largest cancer drug discovery knowledgebase, improvements to treatment response by blocking the EGFR pathway, and a novel noninvasive diagnostic test for immunotherapy-related kidney injury.
